BioCentury
ARTICLE | Company News

Adagio Pharmaceuticals, Cannasat deal

February 15, 2010 8:00 AM UTC

The companies signed a letter of intent granting Cannasat an exclusive option to obtain exclusive, worldwide rights to develop and commercialize Adagio's APL-130277 to treat Parkinson's disease. Cann...